Literature DB >> 23255564

Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis.

Smriti Mehra1, Xavier Alvarez, Peter J Didier, Lara A Doyle, James L Blanchard, Andrew A Lackner, Deepak Kaushal.   

Abstract

BACKGROUND: The BCG vaccine is ineffective against adult tuberculosis. Hence, new antituberculosis vaccines are needed. Correlates of protection against tuberculosis are not known. We studied the effects of BCG vaccination on gene expression in tuberculosis granulomas using macaques.
METHODS: Macaques were BCG-vaccinated or sham-vaccinated and then challenged with virulent Mycobacterium tuberculosis. Lung lesions were used for comparative transcriptomics.
RESULTS: Vaccinated macaques were protected with lower bacterial burden and immunopathology. Lesions from BCG-vaccinated nonhuman primates (NHPs) showed a better balance of α- and β-chemokine gene expression with higher levels of β-chemokine expression relative to nonvaccinated animals. Consistent with this, sham-vaccinated macaques recruited fewer macrophages relative to neutrophils in their lungs. The expression of indoleamine 2,3-dioxygenase (IDO), a known immunosuppressor, was significantly higher in both week 5 and 10 lesions from sham-vaccinated, relative to BCG-vaccinated, NHPs. IDO expression was primarily limited to the nonlymphocytic region of the lesions, within the inner ring structure surrounding the central necrosis.
CONCLUSIONS: Our study defines lung gene expression correlates of protective response against tuberculosis, relative to disease, which can potentially be employed to assess the efficacy of candidate antituberculosis vaccines. Mycobacterium tuberculosis may modulate protective immune responses using diverse mechanisms, including increased recruitment of inflammatory neutrophils and the concomitant use of IDO to modulate inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255564      PMCID: PMC3633457          DOI: 10.1093/infdis/jis778

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position.

Authors:  Karin Reif; Eric H Ekland; Lars Ohl; Hideki Nakano; Martin Lipp; Reinhold Förster; Jason G Cyster
Journal:  Nature       Date:  2002-03-07       Impact factor: 49.962

2.  The Achilles heel of BCG.

Authors:  Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2010-07-24       Impact factor: 3.131

3.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

Authors:  Seok-Yong Eum; Ji-Hye Kong; Min-Sun Hong; Ye-Jin Lee; Jin-Hee Kim; Soo-Hee Hwang; Sang-Nae Cho; Laura E Via; Clifton E Barry
Journal:  Chest       Date:  2009-09-11       Impact factor: 9.410

4.  B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guérin vaccination against tuberculosis infection in mice.

Authors:  Tatiana K Kondratieva; Elvira I Rubakova; Irina A Linge; Vladimir V Evstifeev; Konstantin B Majorov; Alexander S Apt
Journal:  J Immunol       Date:  2009-12-18       Impact factor: 5.422

5.  Guinea pig neutrophil-macrophage interactions during infection with Mycobacterium tuberculosis.

Authors:  Kirti V Sawant; Hyosun Cho; Mark Lyons; Lan H Ly; David N McMurray
Journal:  Microbes Infect       Date:  2010-06-04       Impact factor: 2.700

Review 6.  Prospects for new vaccines against tuberculosis.

Authors:  I M Orme
Journal:  Trends Microbiol       Date:  1995-10       Impact factor: 17.079

7.  Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

Authors:  Jamie Harper; Ciaran Skerry; Stephanie L Davis; Rokeya Tasneen; Mariah Weir; Igor Kramnik; William R Bishai; Martin G Pomper; Eric L Nuermberger; Sanjay K Jain
Journal:  J Infect Dis       Date:  2011-12-23       Impact factor: 5.226

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

9.  Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas.

Authors:  Smriti Mehra; Bapi Pahar; Noton K Dutta; Cecily N Conerly; Kathrine Philippi-Falkenstein; Xavier Alvarez; Deepak Kaushal
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

Review 10.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

View more
  55 in total

1.  Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Authors:  Uma Shanmugasundaram; Allison N Bucsan; Shashank R Ganatra; Chris Ibegbu; Melanie Quezada; Robert V Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Journal:  JCI Insight       Date:  2020-07-23

2.  Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis.

Authors:  Catherine Y Cheng; Nuria M Gutierrez; Mardiana B Marzuki; Xiaohua Lu; Taylor W Foreman; Bhairav Paleja; Bernett Lee; Akhila Balachander; Jinmiao Chen; Liana Tsenova; Natalia Kurepina; Karen W W Teng; Kim West; Smriti Mehra; Francesca Zolezzi; Michael Poidinger; Barry Kreiswirth; Deepak Kaushal; Hardy Kornfeld; Evan W Newell; Amit Singhal
Journal:  Sci Immunol       Date:  2017-03-24

3.  Tryptophan catabolism reflects disease activity in human tuberculosis.

Authors:  Jeffrey M Collins; Amnah Siddiqa; Dean P Jones; Ken Liu; Russell R Kempker; Azhar Nizam; N Sarita Shah; Nazir Ismail; Samuel G Ouma; Nestani Tukvadze; Shuzhao Li; Cheryl L Day; Jyothi Rengarajan; James Cm Brust; Neel R Gandhi; Joel D Ernst; Henry M Blumberg; Thomas R Ziegler
Journal:  JCI Insight       Date:  2020-05-21

Review 4.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

5.  CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.

Authors:  Taylor W Foreman; Smriti Mehra; Denae N LoBato; Adel Malek; Xavier Alvarez; Nadia A Golden; Allison N Bucşan; Peter J Didier; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Chad J Roy; James Blanchard; Marcelo J Kuroda; Andrew A Lackner; John Chan; Shabaana A Khader; William R Jacobs; Deepak Kaushal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

6.  Hypoxia Sensing and Persistence Genes Are Expressed during the Intragranulomatous Survival of Mycobacterium tuberculosis.

Authors:  Teresa A Hudock; Taylor W Foreman; Nirmalya Bandyopadhyay; Uma S Gautam; Ashley V Veatch; Denae N LoBato; Kaylee M Gentry; Nadia A Golden; Amy Cavigli; Michelle Mueller; Shen-An Hwang; Robert L Hunter; Xavier Alvarez; Andrew A Lackner; Joel S Bader; Smriti Mehra; Deepak Kaushal
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

7.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

Review 8.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

9.  A novel microdissection approach to recovering mycobacterium tuberculosis specific transcripts from formalin fixed paraffin embedded lung granulomas.

Authors:  Teresa A Hudock; Deepak Kaushal
Journal:  J Vis Exp       Date:  2014-06-05       Impact factor: 1.355

10.  How well do you know your monkeys?

Authors:  Deepak Kaushal; Rudolf P Bohm; Andrew A Lackner
Journal:  J Med Primatol       Date:  2013-02       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.